AIDA ORTEGA SURI: Open Payments
NPI 1356951545 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 43 payments from 12 companies in 2025. Trend: 2023 $357 · 2024 $729 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $274 |
| GlaxoSmithKline, LLC. | 8 | $153 |
| BioCryst US Sales Co., LLC | 9 | $148 |
| Optinose US, Inc. | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| CSL Behring | 2 | $48 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $36 |
| GENZYME CORPORATION | 1 | $28 |
| Amgen Inc. | 1 | $20 |
Products named: DUPIXENT, ORLADEYO, NUCALA, Xhance, TRELEGY ELLIPTA, AIRSUPRA, NEFFY, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
